https://www.selleckchem.com/pr....oducts/k-ras-g12c-in
inomatosis developing during entrectinib in a ROS1-positive NSCLC patient. This study was designed to develop a nomogram for predicting neutropenia caused by chemotherapy in non-small cell lung cancer (NSCLC) patients. Information was collected from 376 patients between November 2017 and November 2020. The endpoint was chemotherapy-induced neutropenia (absolute neutrophil count 2×10 /L). Logistic regression was performed to appraise the prognostic value of each potential predictor. Risk predictors from the final pred
Like
Comment
Share
